NEW YORK (GenomeWeb News) – Agilent Technologies this week said that it had completed the acquisition of certain assets of A2 Technologies for an undisclosed sum. Agilent inked the agreement last month to acquire specific assets of A2 Technologies, a Danbury, Conn.-based developer of Fourier transform infrared technology for lab and field use.
Dionex this week reported that its second-quarter revenues increased around 14 percent to $124.1 million from $109.2 million year over year. The firm's net income was $18.9 million, or $1.04 per share, compared to $16.9 million, or $.92 per share, for the second quarter of the previous year.
The chromatography systems maker signed a deal in December to be acquired by Thermo Fisher Scientific for approximately $2.1 billion.
The University of California, San Francisco, this week opened its $123 million Ray and Dagmar Dolby Regeneration Medicine Building. The new facility houses the Eli and Edythe Broad Center for Regeneration Medicine and Stem Cell Research at UCSF. No federal funds were used in constructing the facility or purchasing equipment for it, meaning the research conducted there is immune to variations in federal funding policy regarding human embryonic stem cell research, UCSF said in a statement.